Dr. An is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
635 Barnhill Dr
# A128
Indianapolis, IN 46202Phone+1 317-274-4806
Education & Training
- Baylor Scott & White Medical Center - TempleSurgical Pathology, 1997
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Pathology-Anatomic and Clinical, 1996
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Fellowship, Hematopathology, 1997 - 1998
- Cedars-Sinai Medical CenterResidency, Pathology-Anatomic and Clinical, 1992 - 1996
- The University of Texas Health Science Center at San AntonioClass of 1991, M.D.
Certifications & Licensure
- CA State Medical License 1993 - 2027
- FL State Medical License 2011 - 2026
- IL State Medical License 2021 - 2026
- TN State Medical License 2015 - 2026
- TX State Medical License 1998 - 2026
- VA State Medical License 2021 - 2026
- GA State Medical License 2009 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
- Join now to see all
Awards, Honors, & Recognition
- Nathan B. Friedman, M.D. Excellence in Research by a Resident or Fellow Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 1996
Publications & Presentations
PubMed
- 64 citationsChronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.Attilio Orazi, Ronald Chiu, Dennis P. O'Malley, Magdalena Czader, Susan L Allen
Modern Pathology. 2006-10-13 - 18 citationsPrimary pancreatic follicle center-derived lymphoma masquerading as carcinoma.Riley E. Alexander, Attila Nakeeb, Kumar Sandrasegaran, Michael J. Robertson, Caroline An
Gastroenterology & Hepatology. 2011-12-01 - 89 citationsRituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysisKristen N. Ganjoo, Caroline An, Michael J. Robertson, Leo I. Gordon, Joy A. Sen
Leukemia & Lymphoma. 2006-06-01
Professional Memberships
- Member
- Member
- European Association for Hematopathology/Society for HematopathologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: